These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
525 related articles for article (PubMed ID: 29103747)
1. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival. Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747 [TBL] [Abstract][Full Text] [Related]
2. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms. Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392 [TBL] [Abstract][Full Text] [Related]
3. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract. Wooff JC; Weinreb I; Perez-Ordonez B; Magee JF; Bullock MJ Am J Surg Pathol; 2011 Dec; 35(12):1786-93. PubMed ID: 22020045 [TBL] [Abstract][Full Text] [Related]
4. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients. Xiong L; Zeng XL; Guo CK; Liu AW; Huang L BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835 [TBL] [Abstract][Full Text] [Related]
5. Treatment modalities and outcomes of olfactory neuroblastoma. Song CM; Won TB; Lee CH; Kim DY; Rhee CS Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733 [TBL] [Abstract][Full Text] [Related]
6. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000. Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422 [TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine Neoplasms of the Sinonasal Tract: Neuroendocrine Carcinomas and Olfactory Neuroblastoma. Shah K; Perez-Ordóñez B Head Neck Pathol; 2016 Mar; 10(1):85-94. PubMed ID: 26830400 [TBL] [Abstract][Full Text] [Related]
8. [Long-term experiences in the therapy of esthesioneuroblastoma]. Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299 [TBL] [Abstract][Full Text] [Related]
10. Olfactory Neuroblastoma with Divergent Differentiation: An Unusual Histologic Finding in a Rare Tumor. Meyer C; Hamersley ERS; Manosalva RE; Torske K; McIntyre N; Mitchell A Head Neck Pathol; 2017 Dec; 11(4):531-536. PubMed ID: 28168398 [TBL] [Abstract][Full Text] [Related]
11. Cytopathologic features of olfactory neuroblastoma. Mahooti S; Wakely PE Cancer; 2006 Apr; 108(2):86-92. PubMed ID: 16456848 [TBL] [Abstract][Full Text] [Related]
12. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role? Singh L; Ranjan R; Madan R; Arava SK; Deepak RK; Singh MK Ann Diagn Pathol; 2015 Dec; 19(6):391-6. PubMed ID: 26343569 [TBL] [Abstract][Full Text] [Related]
13. Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma. Bell D Head Neck Pathol; 2018 Mar; 12(1):22-30. PubMed ID: 29427030 [TBL] [Abstract][Full Text] [Related]
14. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome. Malouf GG; Casiraghi O; Deutsch E; Guigay J; Temam S; Bourhis J Eur J Cancer; 2013 Apr; 49(6):1324-34. PubMed ID: 23312882 [TBL] [Abstract][Full Text] [Related]
15. Therapy and prognosis of intracranial invasive olfactory neuroblastoma. Jiang GY; Li FC; Chen WK; Liu AM; Cai WQ Otolaryngol Head Neck Surg; 2011 Dec; 145(6):951-5. PubMed ID: 21825099 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma]. Li X; Liu HG; Xie XJ; Han YD; Li M Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117 [TBL] [Abstract][Full Text] [Related]
17. Does sophisticated diagnostic workup on neuroectodermal tumors have an impact on the treatment of esthesioneuroblastoma? Haas I; Ganzer U Onkologie; 2003 Jun; 26(3):261-7. PubMed ID: 12845211 [TBL] [Abstract][Full Text] [Related]
18. Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma. Classe M; Burgess A; El Zein S; Wassef M; Herman P; Mortuaire G; Leroy X; Malouf GG; Verillaud B Histopathology; 2019 Dec; 75(6):853-864. PubMed ID: 31306501 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. McElroy EA; Buckner JC; Lewis JE Neurosurgery; 1998 May; 42(5):1023-7; discussion 1027-8. PubMed ID: 9588546 [TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine and undifferentiated sinonasal and skull base tumors: An up-to-date narrative review. Sideris G; Solomos P; Gogoulos P; Margaris I; Panagoulis E; Vlastarakos P; Karamagkiolas S; Tzagkaroulakis M; Nikolopoulos T; Delides A Oral Maxillofac Surg; 2024 Sep; 28(3):1009-1017. PubMed ID: 38502274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]